Phascolarctos cinereus (koala): 110222594
Help
Entry
110222594 CDS
T05867
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
pcw
Phascolarctos cinereus (koala)
Pathway
pcw01524
Platinum drug resistance
pcw04010
MAPK signaling pathway
pcw04115
p53 signaling pathway
pcw04148
Efferocytosis
pcw04210
Apoptosis
pcw04215
Apoptosis - multiple species
pcw04623
Cytosolic DNA-sensing pathway
pcw04650
Natural killer cell mediated cytotoxicity
pcw04657
IL-17 signaling pathway
pcw04668
TNF signaling pathway
pcw04726
Serotonergic synapse
pcw04932
Non-alcoholic fatty liver disease
pcw04933
AGE-RAGE signaling pathway in diabetic complications
pcw04936
Alcoholic liver disease
pcw05010
Alzheimer disease
pcw05012
Parkinson disease
pcw05014
Amyotrophic lateral sclerosis
pcw05016
Huntington disease
pcw05020
Prion disease
pcw05022
Pathways of neurodegeneration - multiple diseases
pcw05132
Salmonella infection
pcw05133
Pertussis
pcw05134
Legionellosis
pcw05145
Toxoplasmosis
pcw05146
Amoebiasis
pcw05152
Tuberculosis
pcw05160
Hepatitis C
pcw05161
Hepatitis B
pcw05162
Measles
pcw05163
Human cytomegalovirus infection
pcw05164
Influenza A
pcw05165
Human papillomavirus infection
pcw05167
Kaposi sarcoma-associated herpesvirus infection
pcw05168
Herpes simplex virus 1 infection
pcw05169
Epstein-Barr virus infection
pcw05170
Human immunodeficiency virus 1 infection
pcw05200
Pathways in cancer
pcw05203
Viral carcinogenesis
pcw05205
Proteoglycans in cancer
pcw05206
MicroRNAs in cancer
pcw05210
Colorectal cancer
pcw05222
Small cell lung cancer
pcw05416
Viral myocarditis
pcw05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
pcw00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
110222594 (CASP3)
04668 TNF signaling pathway
110222594 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
110222594 (CASP3)
09143 Cell growth and death
04210 Apoptosis
110222594 (CASP3)
04215 Apoptosis - multiple species
110222594 (CASP3)
04115 p53 signaling pathway
110222594 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
110222594 (CASP3)
04650 Natural killer cell mediated cytotoxicity
110222594 (CASP3)
04657 IL-17 signaling pathway
110222594 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
110222594 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
110222594 (CASP3)
05206 MicroRNAs in cancer
110222594 (CASP3)
05205 Proteoglycans in cancer
110222594 (CASP3)
05203 Viral carcinogenesis
110222594 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
110222594 (CASP3)
05222 Small cell lung cancer
110222594 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
110222594 (CASP3)
05161 Hepatitis B
110222594 (CASP3)
05160 Hepatitis C
110222594 (CASP3)
05164 Influenza A
110222594 (CASP3)
05162 Measles
110222594 (CASP3)
05168 Herpes simplex virus 1 infection
110222594 (CASP3)
05163 Human cytomegalovirus infection
110222594 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
110222594 (CASP3)
05169 Epstein-Barr virus infection
110222594 (CASP3)
05165 Human papillomavirus infection
110222594 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
110222594 (CASP3)
05133 Pertussis
110222594 (CASP3)
05134 Legionellosis
110222594 (CASP3)
05152 Tuberculosis
110222594 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
110222594 (CASP3)
05145 Toxoplasmosis
110222594 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
110222594 (CASP3)
05012 Parkinson disease
110222594 (CASP3)
05014 Amyotrophic lateral sclerosis
110222594 (CASP3)
05016 Huntington disease
110222594 (CASP3)
05020 Prion disease
110222594 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
110222594 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
110222594 (CASP3)
05416 Viral myocarditis
110222594 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
110222594 (CASP3)
04932 Non-alcoholic fatty liver disease
110222594 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
110222594 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
110222594 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
pcw01002
]
110222594 (CASP3)
Enzymes [BR:
pcw01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
110222594 (CASP3)
Peptidases and inhibitors [BR:
pcw01002
]
Cysteine peptidases
Family C14: caspase family
110222594 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
110222594
NCBI-ProteinID:
XP_020863340
UniProt:
A0A6P5M564
LinkDB
All DBs
Position
Unknown
AA seq
276 aa
AA seq
DB search
MANTEITVDSKPTKSSVLKILHGSKSAESGLSSDSYKMDYPEMGLCVIINNKNFHPNTGM
SFRSGTDVDAAHLRDTFKNLKYEVRNKNDLTCKEIIELMYNVSKEDHSQRSSFVCVILSH
GEEGIIFGTDGSVELKRLTCFFKGDKCRSLTGKPKLFIIQACRGTELDCGVETDSGTDDD
VTCQKIPIEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYAHKLEIMQILTRVNR
KVATEFESYSLDVNFHAKKQVPCIMSMLTKELYFFP
NT seq
831 nt
NT seq
+upstream
nt +downstream
nt
atggcaaatactgaaattacagtagattcaaaacctaccaaaagttcagtactaaagatc
ctccatggtagcaagtcagcagaatctggattgtcatcagacagctataaaatggattat
ccagaaatggggctatgtgtaataatcaataataaaaattttcacccaaatactggcatg
tcatttcgttctggtacagatgtagatgcagcacacctcagggatacattcaagaacttg
aaatatgaagtcaggaataaaaatgatctgacatgtaaagaaataattgaattaatgtac
aatgtttctaaagaagatcacagccaaaggagcagttttgtttgcgtgattctaagtcat
ggtgaagaaggaatcatctttgggacggatggatctgttgagctgaaaagattaacatgt
ttctttaaaggggataagtgtagaagtctgacaggaaagccaaagctttttattattcag
gcatgtagaggcacagagttggattgtggtgttgaaacagacagtggcactgatgatgat
gtaacatgccagaaaatacctattgaggcagacttcttatatgcatattctacagcccca
ggctactattcttggagaaattcaaaggatggttcgtggtttatccagtcactttgcgca
atgctgaaacagtatgctcacaagcttgagataatgcaaatccttaccagagtcaatcgg
aaggttgctacagagtttgaatcttattccttagatgttaacttccatgcaaagaagcag
gtgccatgtatcatgtccatgcttactaaggaactgtattttttcccctaa
DBGET
integrated database retrieval system